发明名称 Antibody specifically recognizing an epitope for switching to Th2 cell and a method for converting T cell to type 2 helper T cell using the same
摘要 The present invention relates to a novel epitope to convert T cell to type 2 helper T (TH2) cell. Specifically, the present invention relates to an epitope constituting the 20th to 30th amino acids (SEQ ID No. 2) of extracellular domain (ECD) of activation-inducible tumor necrosis factor receptor (AITR), an antibody recognizing the epitope, a polynucleotide encoding the epitope, a polynucleotide encoding the antibody, an expression vector comprising the polynucleotide encoding the epitope or antibody, a transformant introduced with the vector, a composition comprising the antibody for converting T cell to TH2 cell and a method of conversion, a pharmaceutical composition comprising the antibody for preventing or treating autoimmune disease, and a method for treating autoimmune disease using the antibody.
申请公布号 US9255152(B2) 申请公布日期 2016.02.09
申请号 US201313861675 申请日期 2013.04.12
申请人 National Cancer Center 发明人 Kwon Byoung Se
分类号 A61K39/395;C07K16/28;C07K16/30;C07K7/06;C07K14/705;A61K39/00 主分类号 A61K39/395
代理机构 Reinhart Boerner Van Deuren P.C. 代理人 Reinhart Boerner Van Deuren P.C.
主权项 1. An antibody specifically recognizing an epitope of activation-inducible tumor necrosis factor receptor (AITR), wherein the epitope is represented by SEQ ID NO. 2 and wherein the antibody comprises a heavy chain variable region comprising heavy chain complementarity-determining region 1 (CDR1) represented by SEQ ID No. 6; heavy chain CDR2 represented by SEQ ID No. 7; and heavy chain CDR3 represented by SEQ ID No. 8, and a light chain variable region comprising light chain CDR1 represented by SEQ ID No. 10; light chain CDR2 represented by SEQ ID No. 11; and light chain CDR3 represented by SEQ ID No. 12.
地址 Goyang-Si, Gyeonggi-Do KR